A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults
Clinical trial NCT05572879 · COMPLETED
Trial details
- NCT number
- NCT05572879
- Sponsor
- EuBiologics Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2023-06-23
- Enrollment
- 2600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.